|Bid||0.5100 x N/A|
|Ask||0.5300 x N/A|
|Day's Range||0.5200 - 0.5400|
|52 Week Range||0.3500 - 0.7900|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 20, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Approved on July 1 the granting of 40,000 restricted share units to each director of the Company pursuant ...
CALGARY, AB , July 2, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) is pleased to announce that the Board of Directors ...
RS2D also expands the Company's product portfolio with its Pulse console for high-field NMR systems. Full integration of the companies has been completed, highlighted by two RS2D executives taking important leadership positions: Remy Schimpf as Senior VP of Sales, and Julien Muller as Chief Technology Officer. For the three months ended March 31, 2020, the Company reported consolidated revenue of $1,523k, a decrease of $542k over the $2,065k for the comparable period ended March 31, 2019.